Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 3Hodgkin Disease 2Lymphoma, Large B-Cell, Diffuse 1Extensive Stage Small Cell Lung Cancer 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Doxorubicin 13Bleomycin 12Vinblastine 11Prednisone 11Vincristine 10Etoposide 10Cyclophosphamide 10Radiotherapy 9Filgrastim 9Dacarbazine 7Procarbazine 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5ABVD protocol 5Vinorelbine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Gemcitabine 4Cytarabine 4Cisplatin 4Carmustine 4etoposide phosphate 3Mechlorethamine 3Ifosfamide 3indolepropanol phosphate 2Whole-Body Irradiation 2Positron Emission Tomography Computed Tomography 2Polymerase Chain Reaction 2Podophyllotoxin 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Hodgkin Disease × Podophyllotoxin × Clear all
NCT00003389 2023-06-29

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Eastern Cooperative Oncology Group

Phase 3 Completed
854 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡